Rocket Doctor AI Inc. Shares Rise as Company Receives Prestigious Digital Health Award
Rocket Doctor AI Inc. (ticker AIRDF) experienced a notable uptick in trading activity over the past 24 hours, closing 7.1 % higher at 05:34 PM Central Europe on Wednesday, 21 October 2026. The stock is currently priced at approximately USD 0.36 on major exchanges, with a circulating supply of 101.5 million shares. At this level, the company’s market capitalization stands at roughly USD 35.5 million. In the last 24 hours, only USD 33 000 worth of shares changed hands.
The firm’s most recent performance reflects a broader downturn, having declined 16.27 % since the end of last month. Its 200‑day simple moving average sits at USD 0.45, while the all‑time high of the past 52 weeks was USD 0.71 (10 October 2025) and the low was USD 0.32 (15 October 2026).
Award Recognition at HLTH 2026
Rocket Doctor AI was announced as a finalist in the 8th Annual Digital Health & AI Awards, organized by the Digital Health Hub Foundation and presented at HLTH 2026 in Las Vegas. The company, which operates a physician‑built, AI‑powered digital health platform, was selected for its contributions to civic health—particularly in affordability, access, and equity—from a pool of more than 1,800 global applicants. The nomination places Rocket Doctor AI among five “Best in Class” finalists in the same category.
In addition to the award nomination, the firm will be showcased in the “Innovations from Canada” Pavilion and Global Village at HLTH. There, it will present a pitch and demonstrate its technology, underscoring its ongoing efforts to broaden healthcare access for underserved communities in Canada and the United States through AI‑driven solutions.
Market Activity of Peer Stocks
The following table summarizes the recent 24‑hour trading performance of several related stocks:
| Ticker | 24‑hour Change | Current Price (USD) | Market Cap (USD mn) | Notable Recent News |
|---|---|---|---|---|
| BNAI | –6.82 % | 5.17 | 41.7 | Filed report on acquisition of Cataneo GmbH and outlined cost‑reduction plans across integration phases. |
| KFFB | +1.34 % | 5.28 | 42.1 | Current price‑to‑earnings ratio of 22.07. |
| SER | +0.61 % | 1.65 | 41.9 | Announced a new clinical trial phase for its lead product targeting a rare neurological condition, with enrollment slated for early 2027. |
| SCWO | +2.92 % | 2.50 | 42.5 | No additional commentary available. |
| DTSQ | –0.48 % | 11.45 | 42.0 | 10‑Q filing indicates ongoing use of trust account funds while awaiting a business combination; negative nine‑month net income offset by non‑operating income. |
Company Overview
Rocket Doctor AI Inc., trading on the OTC Bulletin Board, is headquartered in the United States. Its platform leverages artificial intelligence to deliver personalized, physician‑guided care for patients seeking convenient access to medical services. The company’s focus on affordability and health equity aligns with broader industry trends toward digital health solutions that reduce barriers to care.
This article provides a comprehensive overview of Rocket Doctor AI’s recent trading performance and industry recognition, contextualized within the broader movements of comparable securities.